⚡ Interrogation des APIs scientifiques en cours…
⚡ Interrogation des APIs scientifiques en cours…
Authors' conclusion
Does not affect the score
Publi-Score
Fidelity
Abstract (PubMed)
This study examines the risk of long COVID following mRNA vaccination, compared with no vaccination, in health care workers in Italy who had COVID-19 infection.
Coeff. authors = avg(0.40, 0.60) = 0.50
Coeff. editorial = avg(1.00, 0.70) = 1.00
min(0.50, 1.00) ← lowest dominates
27.6/50.8 × 0.50 × 100
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
Levin EG — 2021 · The New England Journal of Medicine
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
Andrews N — 2022 · The New England journal of medicine
Protection against Covid-19 by BNT162b2 Booster across Age Groups.
Bar-On YM — 2021 · N Engl J Med
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
Mevorach Dror — 2021 · The New England Journal of Medicine
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectivene…
Charmet T — 2021 · Lancet Regional Health – Europe
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Polack FP — 2020 · New England Journal of Medicine